64 related articles for article (PubMed ID: 15084136)
1. Structure-Activity Relationship Studies of a Macrocyclic AGRP-Mimetic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] Yield Potent and Selective Melanocortin-4 Receptor Antagonists and Melanocortin-5 Receptor Inverse Agonists That Increase Food Intake in Mice.
Fleming KA; Ericson MD; Freeman KT; Adank DN; Lunzer MM; Wilber SL; Haskell-Luevano C
ACS Chem Neurosci; 2018 May; 9(5):1141-1151. PubMed ID: 29363944
[TBL] [Abstract][Full Text] [Related]
2. A cAMP-biosensor-based assay for measuring plasma arginine-vasopressin levels.
Doi K; Kawakami K; Ikuta T; Inoue A
Sci Rep; 2024 Apr; 14(1):9453. PubMed ID: 38658606
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)].
Ericson MD; Freeman KT; Larson CM; Bouchard JL; John K; Lunzer MM; Koerperich ZM; Haskell-Luevano C
ACS Pharmacol Transl Sci; 2024 Apr; 7(4):1114-1125. PubMed ID: 38633589
[TBL] [Abstract][Full Text] [Related]
4. Cis→Trans Isomerization of Pro(7) in Oxytocin Regulates Zn(2+) Binding.
Fuller DR; Glover MS; Pierson NA; Kim D; Russell DH; Clemmer DE
J Am Soc Mass Spectrom; 2016 Aug; 27(8):1376-82. PubMed ID: 27154022
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an
Xu JP; Ding XY; Guo SQ; Wang HY; Liu WJ; Jiang HM; Li YD; Fu P; Chen P; Mei YS; Zhang G; Zhou HB; Jing J
Front Pharmacol; 2023; 14():1132066. PubMed ID: 37021048
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Biological Evaluation of New CRH Analogues.
Papazacharias S; Magafa V; Bernad N; Pairas G; Spyroulias GA; Martinez J; Cordopatis P
Bioinorg Chem Appl; 2010; 2010():. PubMed ID: 20689735
[TBL] [Abstract][Full Text] [Related]
7. Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions.
Gokula V; Terrero D; Joe B
Curr Hypertens Rep; 2022 Dec; 24(12):669-685. PubMed ID: 36301488
[TBL] [Abstract][Full Text] [Related]
8. dDAVP Downregulates the AQP3-Mediated Glycerol Transport
Centrone M; D'Agostino M; Ranieri M; Mola MG; Faviana P; Lippolis PV; Silvestris DA; Venneri M; Di Mise A; Valenti G; Tamma G
Front Cell Dev Biol; 2022; 10():919438. PubMed ID: 35874817
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from
Giribaldi J; Ragnarsson L; Pujante T; Enjalbal C; Wilson D; Daly NL; Lewis RJ; Dutertre S
Mar Drugs; 2020 Mar; 18(3):. PubMed ID: 32155768
[TBL] [Abstract][Full Text] [Related]
10. Structural Elements in the Gαs and Gαq C Termini That Mediate Selective G Protein-coupled Receptor (GPCR) Signaling.
Semack A; Sandhu M; Malik RU; Vaidehi N; Sivaramakrishnan S
J Biol Chem; 2016 Aug; 291(34):17929-40. PubMed ID: 27330078
[TBL] [Abstract][Full Text] [Related]
11. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Alexander SP; Benson HE; Faccenda E; Pawson AJ; Sharman JL; Spedding M; Peters JA; Harmar AJ;
Br J Pharmacol; 2013 Dec; 170(8):1459-581. PubMed ID: 24517644
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.
Manning M; Misicka A; Olma A; Bankowski K; Stoev S; Chini B; Durroux T; Mouillac B; Corbani M; Guillon G
J Neuroendocrinol; 2012 Apr; 24(4):609-28. PubMed ID: 22375852
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and pharmacological characterization of fluorescent peptides for imaging human V1b vasopressin or oxytocin receptors.
Corbani M; Trueba M; Stoev S; Murat B; Mion J; Boulay V; Guillon G; Manning M
J Med Chem; 2011 Apr; 54(8):2864-77. PubMed ID: 21428295
[TBL] [Abstract][Full Text] [Related]
14. The imaging probe development center and the production of molecular imaging probes.
Griffiths GL
Curr Chem Genomics; 2008 Jun; 1():65-9. PubMed ID: 20161829
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
Griffante C; Green A; Curcuruto O; Haslam CP; Dickinson BA; Arban R
Br J Pharmacol; 2005 Nov; 146(5):744-51. PubMed ID: 16158071
[TBL] [Abstract][Full Text] [Related]
16. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
17. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
19. An investigation of position 3 in arginine vasopressin with aliphatic, aromatic, conformationally-restricted, polar and charged amino acids.
Stoev S; Cheng LL; Olma A; Klis WA; Manning M; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1999 Mar; 5(3):141-53. PubMed ID: 10323558
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
